264 related articles for article (PubMed ID: 16998554)
1. [Dosaging of proton pumps inhibitors].
Brørs O
Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2397-9. PubMed ID: 16998554
[No Abstract] [Full Text] [Related]
2. [Dosaging of proton pumps inhibitors].
Lundin KE; Kett K
Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2985; author reply 2985. PubMed ID: 17117203
[No Abstract] [Full Text] [Related]
3. Recurrent anaphylaxis linked to pantoprazole.
Kollmeier AP; Eddleston J; Zuraw BL; Christiansen SC
J Allergy Clin Immunol; 2004 Oct; 114(4):975-7. PubMed ID: 15480345
[No Abstract] [Full Text] [Related]
4. [Pharmacogenomical aspects of gastroesophageal reflux disease].
Isaev VA
Vestn Ross Akad Med Nauk; 2005; (6):33-6. PubMed ID: 16022110
[TBL] [Abstract][Full Text] [Related]
5. Rabeprazole experience in Korea; focus on CYP2C19 polymorphism.
Park SH
J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S20-1. PubMed ID: 16359345
[No Abstract] [Full Text] [Related]
6. [Cytochrome P450 2C19 genotype -based second line therapy with amoxicillin and lansoprazole after failure of initial helicobacter pylori eradication therapy].
Asano M; Taniwaki H; Tsuji D; Sato Y; Shimizu T
Nihon Rinsho; 2005 Dec; 63 Suppl 12():450-3. PubMed ID: 16416832
[No Abstract] [Full Text] [Related]
7. [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy: CYP2C19 polymorphism].
Shirai N; Furuta T
Nihon Rinsho; 2002 Feb; 60 Suppl 2():439-44. PubMed ID: 11979823
[No Abstract] [Full Text] [Related]
8. [Investigation about 3rd line eradication of H. pylori].
Nakagawa S; Kato M; Shimizu Y; Nakagawa M; Asaka M
Nihon Rinsho; 2005 Nov; 63 Suppl 11():466-9. PubMed ID: 16363580
[No Abstract] [Full Text] [Related]
9. [Drug interactions. Proton pump inhibitors II].
Zaigler M
Internist (Berl); 1998 Sep; 39(9):978-9. PubMed ID: 9788120
[No Abstract] [Full Text] [Related]
10. CYP2C19 genotype and the PPIs--focus on rabeprazole.
Lim PW; Goh KL; Wong BC
J Gastroenterol Hepatol; 2005 Dec; 20 Suppl():S22-8. PubMed ID: 16359346
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
[TBL] [Abstract][Full Text] [Related]
12. [Recent topics on important drugs for H. pylori eradication: Rabeprazole].
Sugimoto M; Furuta T; Nakmura A; Shirai N
Nihon Rinsho; 2005 Nov; 63 Suppl 11():350-3. PubMed ID: 16363558
[No Abstract] [Full Text] [Related]
13. Apparent anaphylaxis associated with pantoprazole.
Gratacós L; Soy D; Lluís M; López B; Nicolás JM; Codina C; Nogué S; Ribas J
Am J Health Syst Pharm; 2005 Jul; 62(13):1388-9. PubMed ID: 15972383
[No Abstract] [Full Text] [Related]
14. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
Meyer UA
Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
[TBL] [Abstract][Full Text] [Related]
15. Determinants of non-response in Helicobacter pylori eradication trials.
Klotz U; Treiber G; Schwab M
J Gastroenterol Hepatol; 2005 Sep; 20(9):1471. PubMed ID: 16105147
[No Abstract] [Full Text] [Related]
16. [High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Shirai N; Furuta T; Sugimoto M; Nakamura A
Nihon Rinsho; 2005 Nov; 63 Suppl 11():438-41. PubMed ID: 16363575
[No Abstract] [Full Text] [Related]
17. [Are proton pump inhibitors safe?].
Creutzfeldt W
Internist (Berl); 1994 Dec; 35(12):1137-46. PubMed ID: 7883517
[No Abstract] [Full Text] [Related]
18. [When sour does not make merry at all . Fast relief for patients with reflux].
MMW Fortschr Med; 2003 Apr; 145(15):64. PubMed ID: 15104274
[No Abstract] [Full Text] [Related]
19. Review article: relationship between the metabolism and efficacy of proton pump inhibitors--focus on rabeprazole.
Horn J
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 6():11-9. PubMed ID: 15496214
[TBL] [Abstract][Full Text] [Related]
20. Which proton pump inhibitor should we use?
Williams CN
Can J Gastroenterol; 1997; 11(1):29. PubMed ID: 9113794
[No Abstract] [Full Text] [Related]
[Next] [New Search]
